271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145

79 trials found

diseases per page:

Showing 1 to 10 of 79 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05155098 (ClinicalTrials.gov)	March 1, 2022	30/11/2021	2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness ...	2 Years Prospective Study to Collect Real-life Data On the Retention, Quality of Life, Effectiveness ...	Moderate to Severe Plaque Psoriasis;Psoriatic Arthritis;Ankylosing Spondylitis;Non-radiographic Axia ...	Other: secukinumab	Novartis Pharmaceuticals	NULL	Not yet recruiting	18 Years	80 Years	All	360		NULL
2	EUCTR2020-004284-98-GR (EUCTR)	15/07/2021	05/04/2021	Secukinumab open label roll-over extension protocol	An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored S ...	Psoriatic Arthritis, Ankylosing Spondylitis, non-radiographic axial spondyloarthritis, Severe Chroni ...	Trade Name: Cosentyx Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: secukinumab Oth ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	628	Phase 4	United States;Czechia;Greece;Spain;Guatemala;Russian Federation;Colombia;India;Egypt;Mexico;Poland;B ...
3	EUCTR2020-004284-98-BG (EUCTR)	05/02/2021	29/01/2021	Secukinumab open label roll-over extension protocol	An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored S ...	Psoriatic Arthritis, Ankylosing Spondylitis, non-radiographic axial spondyloarthritis, Severe Chroni ...	Trade Name: Cosentyx Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: secukinumab Oth ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	628	Phase 4	United States;Czechia;Greece;Spain;Guatemala;Turkey;Russian Federation;Colombia;India;Egypt;Czech Re ...
4	EUCTR2019-001177-90-SE (EUCTR)	30/06/2020	17/12/2019	Study to demonstrate the efficacy, safety and tolerability of an intravenous(i.v.) regimen of secuki ...	A randomized, double-blind, placebo-controlled, parallel group, phase IIImulticenter study of intrav ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: Secukinumab Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 3	United States;Czechia;Philippines;Greece;Thailand;Guatemala;Turkey;Russian Federation;Colombia;Italy ...
5	EUCTR2019-001177-90-IT (EUCTR)	06/05/2020	19/05/2021	Study to demonstrate the efficacy, safety and tolerability of an intravenous(i.v.) regimen of secuki ...	A randomized, double-blind, placebo-controlled, parallel group, phase IIImulticenter study of intrav ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: Secukinumab Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 3	United States;Czechia;Philippines;Greece;Thailand;Guatemala;Turkey;Russian Federation;Colombia;Italy ...
6	EUCTR2019-001177-90-BG (EUCTR)	07/04/2020	12/02/2020	Study to demonstrate the efficacy, safety and tolerability of an intravenous(i.v.) regimen of secuki ...	A randomized, double-blind, placebo-controlled, parallel group, phase IIImulticenter study of intrav ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: Secukinumab Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 3	United States;Philippines;Czechia;Greece;Thailand;Guatemala;Turkey;Russian Federation;Colombia;Italy ...
7	EUCTR2019-001177-90-CZ (EUCTR)	20/02/2020	19/12/2019	Study to demonstrate the efficacy, safety and tolerability of an intravenous(i.v.) regimen of secuki ...	A randomized, double-blind, placebo-controlled, parallel group, phase IIImulticenter study of intrav ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: Secukinumab Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 3	Korea, Republic of;Sweden;Bulgaria;Malaysia;Brazil;Belgium;Poland;Czech Republic;Egypt;India;Italy;C ...
8	EUCTR2019-001177-90-GR (EUCTR)	23/01/2020	13/11/2019	Study to demonstrate the efficacy, safety and tolerability of an intravenous(i.v.) regimen of secuki ...	A randomized, double-blind, placebo-controlled, parallel group, phase IIImulticenter study of intrav ...	Axial Spondyloarthritis MedDRA version: 21.1;Level: PT;Classification code 10071400;Term: Axial spon ...	Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: Secukinumab Other descriptive name: ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	500	Phase 3	United States;Czechia;Philippines;Greece;Thailand;Guatemala;Turkey;Russian Federation;Colombia;Italy ...
9	NCT04156620 (ClinicalTrials.gov)	December 11, 2019	8/10/2019	Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of SecukinumabC ...	A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Multicenter Study of Intra ...	Ankylosing Spondylitis or Non-radiographic Axial Spondyloarthritis	Drug: Secukinumab;Drug: Placebo	Novartis Pharmaceuticals	NULL	Active, not recruiting	18 Years	N/A	All	529	Phase 3	United States;Belgium;Brazil;Bulgaria;Colombia;Czechia;Greece;Guatemala;India;Italy;Korea, Republic ...
10	EUCTR2017-000679-10-GR (EUCTR)	05/03/2019	19/12/2018	A randomized, partially-blinded, active-controlled multicenter study of secukinumabto demonstrate re ...	A randomized, partially-blinded, active-controlled multicenter study of secukinumabto demonstrate re ...	Ankylosing spondylitis MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylosing ...	Trade Name: COSENTYX INN or Proposed INN: secukinumab Other descriptive name: SECUKINUMAB Trade Name: H ...	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	837	Phase 3	United States;Portugal;Philippines;Taiwan;Slovakia;Greece;Spain;Russian Federation;Israel;Chile;Colo ...

First Previous1 2 3 4 5…8Next Last